OXFORD, Miss., April 16, 2007 (PRIME NEWSWIRE) -- Modern Technology Corp. (Pink Sheets:MODC), a diversified technology development and acquisition company, and its wholly-owned subsidiary, Insight Medical Group, announced today Peter Duesberg, PhD authored an article on the Chromosomal Imbalance Theory of cancer titled "Chromosomal Chaos and Cancer." This article appears in the current May issue of Scientific American and begins on Page 52.
Anthony Welch, Chairman, said: "The appearance of this article is cause for great excitement. The science behind our technology is rapidly entering the mainstream and we stand on the forefront of its practical application, well ahead of the industry. We are standing at the front of a new revolution in cancer theory and detection. As investors may recall, Peter Duesberg is the co-inventor of the AnuCyte Cancer Detection system and is our lead scientific advisor. His most recent article on cancer, in one of the nation's most popular science publications, brings further recognition to the Chromosomal Theory of cancer. With each passing week, we receive more awareness on what is finally the correct explanation of cancer. Our cancer detection technology is designed around the scientific research of David Rasnick and Peter Duesberg and has demonstrated itself to work as expected: It detects and measures the presence and levels of chromosomal imbalance within the nuclei of cells. This trait is common to all cancers and is not found in any normal cell. Therefore, the detection and measurement of the imbalance is in fact the detection of cancer at all stages. We have the ability to detect and measure these imbalances before the cells show any morphological or histological signs of cancers. We believe this type of detection represents an early detection technique not presently in existence. We believe our system not only is the single most accurate method of detecting cancer within a cell sample, but also it can detect cancer at the earliest possible stage by a clear and accurate measurement of the chromosomal imbalance within the nuclei of a cell population. Because chromosomal imbalance is correlated to cancer 100% of the time and appears in 0% of normal cells, the accuracy of our system approaches the theoretical maximum of 100% detection accuracy for all cancer types at all stages."
About AnuCyte's Inventors:
The inventor of the AnuCyte system, Dr. David Rasnick, PhD, and his scientific research collaborator, Dr. Peter Duesberg, PhD, have been prominent names internationally for many years for their research and publications. On many occasions both have appeared internationally on television, in magazines, newspapers and scientific publications. Peter Duesberg is author of the widely available book: "Inventing the AIDS Virus."
In 1970, Peter Duesberg isolated the first cancer gene through his work on retroviruses and mapped the genetic structure of these viruses. This and his subsequent work in the same field resulted in his election to the National Academy of Sciences in 1986. He was also the recipient of a seven-year Outstanding Investigator Grant from the National Institute of Health. He has been invited to become an Honorary Member of the World Innovation Foundation alongside 91 Nobel Laureates. (www.thewif.org.uk)
About the AnuCyte Cancer Detection System
The AnuCyte Cancer Detection System is an automated machine to detect the presence of cancer in cell samples. The system accurately identifies cancer at any stage in its development and also identifies healthy cancer-free cells in the same test within the same sample. The system is designed based on the chromosomal imbalance theory of cancer. The science behind the company's cancer detection technology is of the very highest standard. Over the prior ten years the chromosomal imbalance theory of cancer has been proven correct both experimentally and theoretically in numerous, rigorously peer-reviewed publications in the leading journals. For a White Paper on the system and the science, you may acquire a copy from this link: http://www.insightmedicalgroup.com/library/IMG_White_Paper.pdf
About Insight Medical Group and Modern Technology Corp.
Insight Medical Group, a wholly-owned subsidiary of Modern Technology Corp., is a specialized biosciences development company whose mission is to bring world-changing medical technology and research to market in the areas of cancer and AIDS. The AnuCyte Cancer Detection System was invented by Dr. David Rasnick, PhD. The technology behind AnuCyte and the chromosomal imbalance theory is the result of 45 years of combined cancer research by Dr. David Rasnick, PhD and Dr. Peter Duesberg, PhD, who continues his studies on cancer research at the University of California, Berkeley. Modern Technology Corp., a bioscience technology development and acquisition company, builds revenues through a model of continuous growth, strategic acquisitions, and commercialization of nascent technology. MODC is a fully-reporting public company with the U.S. Securities and Exchange Commission. For the company's SEC filings, visit www.sec.gov. The company's web address is: http://www.moderntechnologycorp.com
Safe-Harbor Statement
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.